Device Transplant

Xvivo Perfusion System (Xps)

Payments companies reported to CMS as associated with Xvivo Perfusion System (Xps). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$89Kassociated payments (2023-2025)
145clinicians with associated payments
1company reporting

By year

2024 $51K
2025 $38K

Payments reported as associated with Xvivo Perfusion System (Xps), per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $36K
Surgery $10K
Transplant Surgery $9,092
Pulmonary Disease $6,539
Vascular Surgery $5,516
Advanced Heart Failure and Transplant Cardiology $3,750

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Xvivo Perfusion System (Xps)

These are the largest totals companies reported as associated with Xvivo Perfusion System (Xps). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Toshihiro Okamoto Cleveland, OH $15,135.23
Stephanie Chang New York, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,239.94
Ezequiel Molina Atlanta, GA Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,000.00
Mindaugas Rackauskas Gainesville, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,887.62
Leonardo Paim Nicolau Da Costa Tampa, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,019.02
James Kirklin Birmingham, AL Vascular Surgery $3,000.00
David Mcgiffin Birmingham, AL Vascular Surgery $2,500.00
Jorge Mallea Jacksonville, FL Pulmonary Disease $2,294.04
Farooq Sheikh Washington, DC Advanced Heart Failure and Transplant Cardiology $2,250.00
Linda Sher Los Angeles, CA Transplant Surgery $2,195.80

Prescribed Xvivo Perfusion System (Xps)?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.